UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 224

Sortiert nach

Retinoids and Rexinoids in Cancer Prevention: From Laboratory to Clinic

Seminars in oncology, 2016-02, Vol.43 (1), p.49-64

2016

Volltextzugriff (PDF)

Molecular Pathways: Targeting Protein Tyrosine Phosphatases in Cancer

Clinical cancer research, 2017-05, Vol.23 (9), p.2136-2142

2017

Volltextzugriff (PDF)

Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer

Clinical cancer research, 2015-04, Vol.21 (7), p.1688-1698

2015

Volltextzugriff (PDF)

Growth of Triple-Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8

Cancer research (Chicago, Ill.), 2013-06, Vol.73 (11), p.3470-3480

2013

Volltextzugriff (PDF)

Molecularly targeted therapies for p53-mutant cancers

Cellular and molecular life sciences : CMLS, 2017-11, Vol.74 (22), p.4171-4187

2017

Volltextzugriff (PDF)

ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors

Cancer discovery, 2015-07, Vol.5 (7), p.752-767

2015

Volltextzugriff (PDF)

Somatic mutation load of estrogen receptor-positive breast tumors predicts overall survival: an analysis of genome sequence data

Breast cancer research and treatment, 2014-07, Vol.146 (1), p.211-220

2014

Volltextzugriff (PDF)

SOX9 Is Essential for Triple-Negative Breast Cancer Cell Survival and Metastasis

Molecular cancer research, 2020-12, Vol.18 (12), p.1825-1838

2020

Volltextzugriff (PDF)

Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement

The lancet oncology, 2009-05, Vol.10 (5), p.501-507

2009

Volltextzugriff (PDF)

Targeted therapy for breast cancer prevention

Frontiers in oncology, 2013-09, Vol.3, p.250-250

2013

Volltextzugriff (PDF)

Maternal Embryonic Leucine Zipper Kinase (MELK) as a Novel Mediator and Biomarker of Radioresistance in Human Breast Cancer

Clinical cancer research, 2016-12, Vol.22 (23), p.5864-5875

2016

Volltextzugriff (PDF)

TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination

The Journal of clinical investigation, 2020-02, Vol.130 (2), p.958-973

2020

Volltextzugriff (PDF)

Preventive therapy for breast cancer: a consensus statement

The lancet oncology, 2011-05, Vol.12 (5), p.496-503

2011

Volltextzugriff (PDF)

Molecular cancer prevention: Current status and future directions

CA: a cancer journal for clinicians, 2015-09, Vol.65 (5), p.345-383

2015

Volltextzugriff (PDF)

Phosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival

Cancer research (Chicago, Ill.), 2016-04, Vol.76 (7), p.1942-1953

2016

Volltextzugriff (PDF)

Targeting the HER/EGFR/ErbB family to prevent breast cancer

Cancer prevention research (Philadelphia, Pa.), 2011-08, Vol.4 (8), p.1149-1157

2011

Volltextzugriff (PDF)

Targeting nuclear hormone receptors for the prevention of breast cancer

Frontiers in medicine, 2023-07, Vol.10, p.1200947-1200947

2023

Volltextzugriff (PDF)

The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth

Breast cancer research : BCR, 2024-02, Vol.26 (1), p.23-23, Article 23

2024

Volltextzugriff (PDF)

Correction: The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth

Breast cancer research : BCR, 2024-03, Vol.26 (1), p.53-53, Article 53

2024

Volltextzugriff (PDF)

The SOX11 transcription factor is a critical regulator of basal-like breast cancer growth, invasion, and basal-like gene expression

Oncotarget, 2016-03, Vol.7 (11), p.13106-13121

2016

Volltextzugriff (PDF)

SLC22A5/OCTN2 expression in breast cancer is induced by estrogen via a novel intronic estrogen-response element (ERE)

Breast cancer research and treatment, 2012-07, Vol.134 (1), p.101-115

2012

Volltextzugriff (PDF)

Naproxen chemoprevention induces proliferation of cytotoxic lymphocytes in Lynch Syndrome colorectal mucosa

Frontiers in immunology, 2023-05, Vol.14, p.1162669-1162669

2023

Volltextzugriff (PDF)

Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion

Breast cancer research and treatment, 2016-08, Vol.158 (3), p.441-454

2016

Volltextzugriff (PDF)

Chemoprevention of hormone receptor-negative breast cancer: new approaches needed

Recent results in cancer research, 2011-01, Vol.188, p.147

2011

Volltextzugriff (PDF)

The phosphatase PPM1A inhibits triple negative breast cancer growth by blocking cell cycle progression

NPJ breast cancer, 2019-07, Vol.5 (1), p.22-11, Article 22

2019

Volltextzugriff (PDF)

1 – 25 von 224

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(212)
Mit Volltextzugriff
(212)

Publikationsform

Artikel
(220)
Buchkapitel
(4)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(132)
Life Sciences & Biomedicine
(131)
Humans
(102)
Oncology
(102)
Female
(72)
Breast Cancer
(55)
Animals
(49)
Mice
(40)
Tumors
(34)
Biological And Medical Sciences
(31)
Cell Line, Tumor
(27)
Medical Sciences
(27)
Breast Neoplasms - Pathology
(25)
Breast Neoplasms - Metabolism
(24)
Breast Neoplasms - Prevention & Control
(24)
Breast Neoplasms - Genetics
(22)
Breast Neoplasms - Drug Therapy
(19)
Receptors, Estrogen - Metabolism
(18)
Cell Biology
(16)
Estrogens
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Retinoids and Rexinoids in Cancer Prevention: From Laboratory to Clinic

Molecular Pathways: Targeting Protein Tyrosine Phosphatases in Cancer

Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer

Growth of Triple-Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8

Molecularly targeted therapies for p53-mutant cancers

ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors

Somatic mutation load of estrogen receptor-positive breast tumors predicts overall survival: an analysis of genome sequence data

SOX9 Is Essential for Triple-Negative Breast Cancer Cell Survival and Metastasis

Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement

Targeted therapy for breast cancer prevention

Maternal Embryonic Leucine Zipper Kinase (MELK) as a Novel Mediator and Biomarker of Radioresistance in Human Breast Cancer

TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination

Preventive therapy for breast cancer: a consensus statement

Molecular cancer prevention: Current status and future directions

Phosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival

Targeting the HER/EGFR/ErbB family to prevent breast cancer

Targeting nuclear hormone receptors for the prevention of breast cancer

The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth

Correction: The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth

The SOX11 transcription factor is a critical regulator of basal-like breast cancer growth, invasion, and basal-like gene expression

SLC22A5/OCTN2 expression in breast cancer is induced by estrogen via a novel intronic estrogen-response element (ERE)

Naproxen chemoprevention induces proliferation of cytotoxic lymphocytes in Lynch Syndrome colorectal mucosa

Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion

Chemoprevention of hormone receptor-negative breast cancer: new approaches needed

The phosphatase PPM1A inhibits triple negative breast cancer growth by blocking cell cycle progression

Suchergebnisse filtern